Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02571634 · ClinicalTrials.gov registry record · Phase 4
Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints
A Phase 4 study of Minor Procedural Pain, sponsored by Defense and Veterans Center for Integrative Pain Management.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT02571634 is a Phase 4 study of Minor Procedural Pain that has completed, run by Defense and Veterans Center for Integrative Pain Management. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02571634, a Phase 4 study of Minor Procedural Pain, has completed, sponsored by Defense and Veterans Center for Integrative Pain Management.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness, feasibility and safety of intranasal fentanyl (Lazanda) as an alternative to the current gold standard (diazepam) to produce anxiolysis and improve patient comfort during and after radiofrequency ablations of the lumbar facet joints. If this pilot study shows a positive effect and Lazanda is found to be feasible and safe for use during procedures, future larger scale studies can be done.
Conditions Studied
Interventions
- DRUG Lazanda
Study Locations (1)
North Carolina
- Womack Army Medical Center - Fort Bragg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02571634
The ClinicalTrials.gov registry entry for NCT02571634 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Defense and Veterans Center for Integrative Pain Management, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Minor Procedural Pain appearing as the primary indexed condition, and to 1 intervention - of which Lazanda is the first listed.
NCT02571634 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02571634 about?
NCT02571634 is a clinical study titled "Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints". The purpose of this study is to evaluate the effectiveness, feasibility and safety of intranasal fentanyl (Lazanda) as an alternative to the current gold standard (diazepam) to produce anxiolysis and improve patient comfort during and after radiofrequency ablations of the lumbar facet joints. If thi...
What is the current status of trial NCT02571634?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2015-05. Estimated completion is 2016-01.
What conditions does trial NCT02571634 study?
This clinical trial studies the following conditions: Minor Procedural Pain.
What interventions are being tested in trial NCT02571634?
The interventions under investigation include: Lazanda (DRUG).
Who is sponsoring clinical trial NCT02571634?
This trial is sponsored by Defense and Veterans Center for Integrative Pain Management, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02571634 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.